#neutralization — Thursday, May 21, 2026 (1 items)
| 0 | 💬 0 |
Serum Virus-Neutralizing Antibody Titers in Clinical Trial Participants With and Without Immunocompromise Receiving Pemivibart, a Long-Acting Monoclonal Antibody for COVID-19.
(academic.oup.com)
|
Journal of Infectious Diseases 2026-05-21 | #covid-19 #immunity #antibody #neutralization #immunocompromise |